We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2501
Safe Bulkers
SB
$917M
| $497K | ﹤0.01% |
+78,768
| New | +$526K |
2026 Q2
0 quarters
|
|
2502
Firefly Aerospace
FLY
$3.33B
| $497K | ﹤0.01% |
16,900
-29,000
| -63% | -$1.08M |
2025 Q3
3 quarters
|
|
2503
Nautilus Biotechnolgy
NAUT
$368M
| $497K | ﹤0.01% |
265,582
-54,300
| -17% | -$143K |
2025 Q4
2 quarters
|
|
2504
WisdomTree
WT
$3.22B
| $495K | ﹤0.01% |
29,199
-48,100
| -62% | -$852K |
2023 Q2
12 quarters
|
|
2505
Advantage Solutions
ADV
$367M
| $494K | ﹤0.01% |
+11,417
| New | +$404K |
2026 Q2
0 quarters
|
|
2506
Danaher
DHR
$163B
| $493K | ﹤0.01% |
2,589
-7,911
| -75% | -$1.44M |
2026 Q1
1 quarter
|
|
2507
Unusual Machines
UMAC
$893M
| $492K | ﹤0.01% |
22,054
-145,306
| -87% | -$2.69M |
2026 Q1
1 quarter
|
|
2508
Rigetti Computing
RGTI
$4.15B
| $491K | ﹤0.01% |
+25,431
| New | +$492K |
2026 Q2
0 quarters
|
|
2509
SharonAI Holdings
SHAZ
$922M
| $491K | ﹤0.01% |
5,800
-31,872
| -85% | -$1.8M |
2026 Q1
1 quarter
|
|
2510
Oramed Pharmaceuticals
ORMP
$173M
| $490K | ﹤0.01% |
101,953
-157,658
| -61% | -$628K |
2025 Q4
2 quarters
|
|
2511
Aemetis
AMTX
$94.5M
| $490K | ﹤0.01% |
298,800
-580,883
| -66% | -$1.42M |
2025 Q3
3 quarters
|
|
2512
Compañía de Cervecerías Unidas
CCU
$1.97B
| $490K | ﹤0.01% |
+43,707
| New | +$507K |
2026 Q2
0 quarters
|
|
2513
Corcept Therapeutics
CORT
$9.47B
| $489K | ﹤0.01% |
5,628
-13,064
| -70% | -$789K |
2026 Q1
1 quarter
|
|
2514
Concentrix
CNXC
$1.9B
| $489K | ﹤0.01% |
21,834
-32,160
| -60% | -$839K |
2024 Q2
8 quarters
|
|
2515
Voyager Therapeutics
VYGR
$107M
| $488K | ﹤0.01% |
+139,422
| New | +$529K |
2026 Q2
0 quarters
|
|
2516
Assembly Biosciences
ASMB
$413M
| $487K | ﹤0.01% |
17,735
-145,665
| -89% | -$3.97M |
2025 Q3
3 quarters
|
|
2517
Mineralys Therapeutics
MLYS
$1.87B
| $486K | ﹤0.01% |
18,000
+9,013
| +100% | +$247K |
2025 Q4
2 quarters
|
|
2518
Charter Communications
CHTR
$12B
| $484K | ﹤0.01% |
+3,400
| New | +$567K |
2026 Q2
0 quarters
|
|
|
BZH
2519
DELISTED
Beazer Homes USA
BZH
| $482K | ﹤0.01% |
17,200
-1,429
| -8% | -$33.8K |
2026 Q1
1 quarter
|
|
2520
Hooker Furnishings Corp
HOFT
$139M
| $479K | ﹤0.01% |
+26,866
| New | +$367K |
2026 Q2
0 quarters
|
|
2521
Eagle Capital Select Equity ETF
EAGL
$4.91B
| $478K | ﹤0.01% |
+14,871
| New | +$481K |
2026 Q2
0 quarters
|
|
2522
Venu Holding Corp
VENU
$72.3M
| $476K | ﹤0.01% |
209,721
-61,601
| -23% | -$220K |
2025 Q4
2 quarters
|
|
2523
WSFS Financial
WSFS
$4.03B
| $476K | ﹤0.01% |
6,200
-4,500
| -42% | -$323K |
2026 Q1
1 quarter
|
|
2524
RingCentral
RNG
$7.15B
| $476K | ﹤0.01% |
+12,200
| New | +$493K |
2026 Q2
0 quarters
|
|
2525
Nuvation Bio
NUVB
$1.6B
| $474K | ﹤0.01% |
83,402
-20,144
| -19% | -$98.5K |
2025 Q2
4 quarters
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.